Global, regional, and national epidemiology of migraine and tension-type headache in youths and young adults aged 15-39 years from 1990 to 2019: findings from the global burden of disease study 2019
89 A double-blind, placebo-controlled study in veterans with post-traumatic stress disorder (PTSD) and SUD found a 48% decrease in depressive symptoms and a 32% decrease in self-reported PTSD symptoms, results that were significantly better than placebo (15% and 3%, respectively)
Alternative Names: AOD-9604 Studies and Research Data AOD 9604 Research on Molecular Structure Investigations have suggested that only a small segment of the hGH molecule may play a role in lipid regulation
Side Effects & Safety Injection site reactions mild redness or swelling, resolves quickly (documented in clinical-era adverse-event reports) Flushing brief facial warmth Dizziness mild and transient (uncommon) Headache uncommon, typically mild Favorable safety profile Sermorelin's clinical-era trial record documented a favorable adverse-event profile across its years of approved diagnostic use (Prakash & Bhatt, 2020) No significant drug interactions identified during clinical era Documented exclusion criteria: Clinical protocols documented exclusion criteria including active malignancy (on theoretical concern about growth-promoting effects), pregnancy or breastfeeding, and severe renal or hepatic impairment